← Back to Search

Mindful Adaptive Practice in Pregnancy Therapy for Anxiety (TAPS Trial)

N/A
Waitlist Available
Led By Sophie Grigoriadis, MD, PhD
Research Sponsored by Sunnybrook Health Sciences Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
At 12-30weeks gestation
Score > 7 on the GAD-7
Timeline
Screening 3 weeks
Treatment Varies
Follow Up after therapy (4 weeks), 3 months post-therapy, and 6 months post-therapy
Awards & highlights

TAPS Trial Summary

This study is evaluating whether a virtual treatment can reduce anxiety in pregnant women.

Eligible Conditions
  • Anxiety
  • Pregnancy

TAPS Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
, the fetal brain has formed The brain of a fetus at 12-30 weeks gestation has formed.

TAPS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~after therapy (4 weeks), 3 months post-therapy, and 6 months post-therapy
This trial's timeline: 3 weeks for screening, Varies for treatment, and after therapy (4 weeks), 3 months post-therapy, and 6 months post-therapy for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Participant Adherence to therapy as measured by proportion of participants who attend all sessions of therapy
Participant Adherence to therapy as measured by proportion of participants who attend each session of therapy
Participant Adherence to therapy as measured by recorded reasons for dropout
+10 more
Secondary outcome measures
Anxiety symptoms as measured by the GAD-7
Other outcome measures
Adverse effects
Clinician rated anxiety as assessed by the Hamilton Anxiety Rating Scale (HAM-A)
Coronavirus anxiety as assessed by the COVID Anxiety Scale (CAS)
+9 more

TAPS Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Mindful Adaptive Practice in Pregnancy TherapyExperimental Treatment2 Interventions
Participants allocated to the intervention group will have access to treatment as usual in addition to synchronous virtual MAPP. MAPP draws upon existing integrative principles of structured psychotherapies (mindfulness-based, cognitive, behavioural and relational psychotherapy)
Group II: Treatment as usualActive Control1 Intervention
All participants allocated to the control group will have access to standard care.

Find a Location

Who is running the clinical trial?

Sunnybrook Health Sciences CentreLead Sponsor
651 Previous Clinical Trials
1,542,629 Total Patients Enrolled
11 Trials studying Anxiety
4,924 Patients Enrolled for Anxiety
Sunnybrook Research InstituteOTHER
31 Previous Clinical Trials
215,810 Total Patients Enrolled
Women's College HospitalOTHER
99 Previous Clinical Trials
38,711 Total Patients Enrolled
2 Trials studying Anxiety
217 Patients Enrolled for Anxiety

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

How old are they?
18 - 65
What site did they apply to?
Women's College Hospital
What portion of applicants met pre-screening criteria?
Met criteria

How responsive is this trial?

Typically responds via
Email
Most responsive sites:
  1. Women's College Hospital: < 24 hours
Average response time
  • < 1 Day
~18 spots leftby Mar 2025